Author Index

Search or browse for an author across our entire electronic archive

Search results for: E
Results 1 - 10 of 518 shown below

  • EI-Hariry, I

    I EI-Hariry, M Pignatelli and N R Lemoine

    FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines

    doi:10.1054/bjoc.2001.1813

    Abstract | Full article | PDF

  • EL, D Ad

    M Lotem, T Peretz, O Drize, Z Gimmon, D Ad EL, R Weitzen, H Goldberg, I Ben David, D Prus, T Hamburger and E Shiloni

    Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV)

    doi:10.1038/sj.bjc.6600251

    Abstract | Full article | PDF

  • EL-Khateeb, M S

    I S Mahmoud, M A Sughayer, H A Mohammad, A A Eshtayeh, A S Awidi, M S EL-Khateeb and S I Ismail

    The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604512

    Abstract | Full article | PDF

  • Eads, D

    N Dunlap, G G Schwartz, D Eads, S D Cramer, A B Sherk, V John and C Koumenis

    1alpha,25-Dihydroxyvitamin D3 (calcitriol) and its analogue, 19-nor-1alpha,25(OH)2D2, potentiate the effects of ionising radiation on human prostate cancer cells

    doi:10.1038/sj.bjc.6601161

    Abstract | Full article | PDF

  • Eardley, A

    P S Sengupta, G C Jayson, R J Slade, A Eardley and J A Radford

    An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre

    doi:10.1038/sj.bjc.6690376

    Abstract | Full article | PDF

  • R Harrison, P Dey, N J Slevin, A Eardley, A Gibbs, R Cowan, J P Logue, V Leidecker and P Hopwood

    Randomized controlled trial to assess the effectiveness of a videotape about radiotherapy

    doi:10.1054/bjoc.2000.1536

    Abstract | Full article | PDF

  • Earl, H

    S Madhusudan, A Protheroe, D Propper, C Han, P Corrie, H Earl, B Hancock, P Vasey, A Turner, F Balkwill, S Hoare and A L Harris

    A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer

    doi:10.1038/sj.bjc.6601321

    Abstract | Full article | PDF

  • A Rohatiner, J Radford, D Deakin, H Earl, S B Love, O Price, A Wilson and T A Lister

    A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma

    doi:10.1054/bjoc.2001.1822

    Abstract | Full article | PDF

  • Earl, H M

    A M Wardley, L Hiller, H C Howard, J A Dunn, A Bowman, R E Coleman, I N Fernando, D M Ritchie, H M Earl and C J Poole

    tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604538

    Abstract | Full article | PDF

  • H M Earl, L Hiller, J A Dunn, S Bathers, P Harvey, A Stanley, R J Grieve, R K Agrawal, I N Fernando, A M Brunt, K McAdam, S O'Reilly, D W Rea, D Spooner and C J Poole

    NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life

    advance online publication, 2008-09-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604674

    Abstract | Full article | PDF

  • Earl, Helena

    Helena Earl

    Book Reviews

    doi:10.1038/sj.bjc.6690671

    Abstract | Full article | PDF

  • Earl, J

    U Werneke, J Earl, C Seydel, O Horn, P Crichton and D Fannon

    Potential health risks of complementary alternative medicines in cancer patients

    doi:10.1038/sj.bjc.6601560

    Abstract | Full article | PDF

  • U Werneke, J Earl, C Seydel, O Horn, P Crichton and D Fannon

    Reply: Assessing health risks of complementary alternative medicines in cancer patients

    advance online publication, 2004-07-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602046

    Abstract | Full article | PDF

  • Earl, M J

    R L Balleine, M J Earl, M L Greenberg and C L Clarke

    Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women

    doi:10.1038/sj.bjc.6690249

    Abstract | Full article | PDF